Volume 46, Issue 12 e14442
ORIGINAL ARTICLE

Curcumin nanoemulsion counteracts hepatic and cardiac complications associated with high-fat/high-fructose diet in rats

Marawan Abd Elbaset

Marawan Abd Elbaset

Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt

Search for more papers by this author
Maha Nasr

Corresponding Author

Maha Nasr

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt

Correspondence

Maha Nasr, Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Egypt.

Email: [email protected]

Search for more papers by this author
Bassant M. M. Ibrahim

Bassant M. M. Ibrahim

Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt

Search for more papers by this author
Omar A. H. Ahmed-Farid

Omar A. H. Ahmed-Farid

Department of Physiology, National Organization for Drug Control and Research, Giza, Egypt

Search for more papers by this author
Rofanda M. Bakeer

Rofanda M. Bakeer

Department of Pathology, Faculty of Medicine, Helwan University, Helwan, Egypt

Search for more papers by this author
Nabila S. Hassan

Nabila S. Hassan

Department of Pathology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt

Search for more papers by this author
Rania F. Ahmed

Rania F. Ahmed

Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt

Search for more papers by this author
First published: 27 September 2022
Citations: 14

Abstract

The relationship between the incidence of cardiovascular abnormalities and non-alcoholic fatty liver disease (NAFLD) has long been postulated. Curcumin (CUR) is a potential anti-atherosclerotic agent but its poor water solubility hinders its pharmacological use. Therefore, the present study aimed to investigate the effect of formulation of CUR nanoemulsion prepared using the spontaneous emulsification technique on high fat high fructose (HFHF)-induced hepatic and cardiac complications. Fifty Wistar rats were divided into five groups. CUR nanoemulsion at doses of 5 and 10 mg/kg and conventional powdered CUR at a dose of 50 mg/kg were orally administered daily to rats for two weeks, and compared with normal control and HFHF control. Results revealed that the high dose level of CUR nanoemulsion was superior to conventional CUR in ameliorating the HFHF-induced insulin resistance status and hyperlipidemia, with beneficial impact on rats' recorded electrocardiogram (ECG), serum aspartate aminotransferase (ALT) and alanine aminotransferase (AST) levels, leptin, adiponectin, creatine phosphokinase, lactate dehydrogenase and cardiac troponin-I. In addition, hepatic and cardiac oxidative and nitrosative stresses, oxidative DNA damage and disrupted cellular energy statuses were counteracted. Results were also confirmed by histopathological examination.

Practical applications

The use of curcumin nanoemulsion could be beneficial in combating hepatic and cardiac complications resulting from HFHF diets.

CONFLICT OF INTEREST

The authors declare that they have no competing interests.

DATA AVAILABILITY STATEMENT

The corresponding author will provide the data used in the present work upon request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.